Bioventix – BVXP – Company overview

265 Views

0 Likes

19th October 2016

Introduction to Bioventix (BVXP) by Peter Harrison, CEO
Length: c. 6 mins
Peter Harrison, CEO, tells us what Bioventix does, and discusses the business model.
Essentially BVXP develops antibodies for use in different blood testing machines manufactured by the big names: Roche, Siemens, Abbot, etc. He goes into detail about BVXP antibodies types, and why they’re different – perhaps better, than other antibodies.
BVXP sells antibodies (20% revenue), is paid a royalty paid for each blood test around the world (75% revenue. (5% of revenue comes from pure research, commissioned by companies in the field).
The cost and knowledge to of develop antibodies can either be shared by a partner, as in Siemens with Troponin, (where Siemens have a wealth of research and experience in heart disease, and specifically Troponin); or can be purely BVXP funded and developed.

Videos from Bioventix

33:33

Bioventix (BVXP) ShareSoc presentation October 2018

Bioventix ShareSoc presentation: October 2018 By Peter Harrison, CEO. Includes full year results year ended 30th June 2018. Bioventix PLC is a United Kingdom-based biotechnology company. The principal activity of the Company is the development and supply of antibodies. The Company specializes in the development of sheep monoclonal antibodies (SMAs) for use in immunodiagnostics focusing […]

piworld

15th October 2018

21:17

Bioventix (BVXP) Full Year results June 2016 interview

Length: c 20 mins Peter Harrison, CEO, talks through the latest FY results 30 June 2016 with @tamzinpiworld. He expands on the success of Vitamin D and its future prospects, together with the positive impact of foreign exchange. He goes on to talk about the NT proBNP licence, which comes to an end July 2017, […]

piworld

19th October 2016

445

07:01